INVICTUS ANNOUNCES OPTIONCO HAS RECEIVED ITS LICENSE TO
CULTIVATE
Vancouver,
BC, Canada -- October
15,
2018 --
InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP.
("Invictus"
or
the "Company")
(TSXV: GENE; OTCQX: IVITF; FRA: 8IS1)
is pleased to
announce that OptionCo's Delta
Facility,
located in British Columbia, has received its license to
cultivate cannabis under the Access to Cannabis for Medical
Purposes Regulations ("ACMPR"), effective October 12,
2018.
The Company now has
30 days to exercise its option (the "Option") under the Definitive
Option Agreement (the "Definitive Option
Agreement") (see press releases dated May
16, 2018 and July 18, 2018 for more details). If the Option is
exercised, it will represent the Company's
third cultivation facility licensed by Health Canada under the
ACMPR. Invictus will have licensed cannabis operations in the provinces of
British Columbia, Alberta and Ontario, which is key to the
Company's plan to scale production to meet domestic and
international demand for premium cannabis.
OptionCo has a
cannabis production and research facility located in Delta, British
Columbia (the "Delta Facility"), and an additional property located
in Mission, British Columbia (the "Mission Location")
that is currently
awaiting construction of a 350,000 square foot purpose-built
indoor facility, which will be built in multiple phases. The
Mission Location is located on 32-acres of buildable land. The
property is eligible for wholesale energy costs with 38 MG Watt
service at the property line, and access to an ample water supply
from underground aquifers.
For more
information, please visit
www.invictus-md.com.
On Behalf of the
Board,
Dan
Kriznic
Chairman
and
CEO
Jessica
Martin
Vice
President, Public Relations and Regulatory
Affairs
(833)
879-4363
About
Invictus
Invictus is a
global cannabis company offering a selection of products under a
wide range of lifestyle brands. Our integrated sales approach is
defined by five pillars of distribution including medical,
adult-use, international, Licensed
Producer to Licensed Producer and retail stores.
Invictus has
partnered with business leaders to convey our corporate vision,
including KISS music legend and business mogul Gene Simmons as our
Chief Evangelist Officer. To meet growing demand,
Invictus is
expanding its cultivation footprint, with two cannabis production
facilities fully licensed under the ACMPR in Canada and a third
awaiting approval, featuring 100,000 square feet of available grow
space today with 200,000 expected by January 2019
and
up to
1 million by end of
2020. To accommodate international
sales, Invictus' wholly-owned subsidiary, Acreage Pharms Ltd.
("Acreage Pharms"), has designed and is currently building its Phase 3
and 4 purpose-built cultivation facilities to be European Union
Good Manufacturing Practices ("EU-GMP") compliant.
The Company will
earmark up
to 50 per
cent of production to the medical market. To ensure consistency in
quality and supply, Invictus maintains all aspects of the growing
process through its subsidiary, Future Harvest Development Ltd., a
high-quality Fertilizer and Nutrients manufacturer. Invictus drives
sustainable long-term shareholder value through a diversified
product portfolio with over 69 Health Canada
approved strains and a multifaceted distribution
strategy including medical,
adult-use,
international, Licensed Producer to Licensed
Producer and
retail stores. For more information visit
www.invictus-md.com.
Cautionary
Note Regarding Forward-Looking Statements: This release includes
certain statements and information that may constitute
forward-looking information within the meaning of applicable
Canadian securities laws or forward-looking statements within the
meaning of the United States Private Securities Litigation Reform
Act of 1995. All statements in this news release, other than
statements of historical facts, including statements regarding
future estimates, plans, objectives, timing, assumptions or
expectations of future performance, including the timing,
approval and completion of the Arrangement and related matters
and the
potential production capacity of Invictus, are forward-looking
statements and contain forward-looking information. Generally,
forward-looking statements and information can be identified by the
use of forward-looking terminology such as "intends"
or
"anticipates",
or variations of such words and phrases or statements that certain
actions, events or results "may",
"could",
"should",
"would"
or
"occur".
Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release,
including that Invictus will be successful in reaching its
potential production capacity, its production facilities will be
completed as anticipated, regulatory approval will be granted as
anticipated, Invictus will reach full production capacity on the
timeline anticipated by the Company, and no unforeseen
construction delays
will be experienced. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Important factors that may cause actual results to vary, include,
without limitation, the Company
will not obtain the requisite approvals to complete the
Arrangement, Invictus
will not be successful in reaching its potential production
capacity, its production facilities will not be completed as
anticipated, and licenses or approvals being granted on terms or
timelines that are materially worse than
expected by the Company. Although
management of the Company has attempted to identify important
factors that could cause actual results to differ materially from
those contained in forward-looking statements or forward-looking
information, there may be other factors that cause results not to
be as anticipated, estimated or intended. There can be no assurance
that such statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking statements and forward-looking
information. Readers are cautioned that reliance on such
information may not be appropriate for other purposes. The Company
does not undertake to update any forward-looking statement,
forward-looking information or financial out-look that are
incorporated by reference herein, except in accordance with
applicable securities laws.
Neither the
TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
